EP002 — Healing Peptides


The “heal everything” category — and where the story gets complicated. We go compound by compound through the peptides people reach for to recover: BPC-157, TB-500, GHK-Cu, KPV and more. The theme that emerged on its own? For almost every one, the popular story and the actual evidence don’t quite line up — including one where the best human trial data comes from a company that no longer exists.

LINK to Services

In this episode

Eight healing compounds, one recurring surprise: the gap between what the internet says and what the research actually shows.
•BPC-157 — the “does everything” reputation, the real (if thin) human signals, and the tumor-growth debate nobody likes to bring up.
•TB-500 — why its evidence is actually borrowed from a related molecule… whose own big trial failed.
•GHK-Cu, KPV, LL-37 — the mechanisms, the marketing, and exactly where the data runs out.
•Pentadeca Arginate (PDA) — the newcomer with a big reputation and almost no independent evidence.
•Thymosin Alpha-1 and ARA-290 — genuinely well-studied peptides, for jobs most people aren’t using them for.
•The “ghost trial”: the healing-peptide data point that traces straight back to a company that doesn’t exist anymore.
Not a debunk — a reality check, so you know what’s real before you ask your doctor about it.

Everything discussed on this show is for informational and educational purposes only, based on published research and community-reported experience. We are not doctors, and nothing here constitutes medical advice. Our goal is simple: to give you enough information to have a real, informed conversation with your own physician — one where you walk in knowing the right questions to ask. Please involve a qualified healthcare provider before making any changes to your health protocols. Don’t skip that step.